SP600125 Loaded Liposomes(Lipo-004RG)
Product Summary | |
---|---|
Name | SP600125 Loaded Liposomes |
Download Datasheet | |
Cat No. | Lipo-004RG |
Product Overview | SP600125 (Nsc75890) is a broad-spectrum JNK inhibitor for JNK1, JNK2 and JNK3 with IC50 of 40 nM, 40 nM and 90 nM in cell-free assays, respectively; 10-fold greater selectivity against MKK4, 25-fold greater selectivity against MKK3, MKK6, PKB, and PKC?, and 100-fold selectivity against ERK2, p38, Chk1, EGFR etc. SP600125 is also a broad??pectrum inhibitor of serine/threonine kinases including Aurora kinase A??LT3 and TRKA with of IC50 of 60??M, 90??M and 70??M. SP600125 inhibits autophagy and activates apoptosis. This product is a PEG modified pre-formulated liposome with SP600125 (Nsc75890) loaded. It is supplied ready to use in vitro or in vivo studies. |
Lipid Composition | / |
Active Ingredients | SP600125 |
Form | Liquid |
Storage Buffer | 292 mM sucrose, 0.5% DPBS (1X) |
Concentration | 250 mcg/mL (Concentration Cefixime); Lipid Concentration 60 mM |
Stability | At least 1 month |
Storage | 2 °C to 8 °C (do not freeze), protect from light |
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frequently Asked Questions
-
Can you provide information on the size and composition of your liposomes?
Yes, we offer detailed specifications for each product, enabling researchers to select liposomes that best match their experimental requirements.
-
Do you offer customization options for liposome formulations?
Yes, we offer customization services to meet the unique demands of research projects. Our team of experts can work with customers to develop custom liposome formulations tailored to their specific needs, ensuring optimal results for their experiments.
-
What analytical and characterization data do you provide with your liposome products?
We provide comprehensive analytical and characterization data for all our liposome products, such as size distribution, zeta potential, and encapsulation efficiency.